Related Experiment Video

Updated: Jul 19, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Beta2-agonists for asthma: the pediatric perspective

Padmaja Subbarao1, Felix Ratjen

  • 1Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. padmaja.subbarao@sickkids.ca

Clinical Reviews in Allergy & Immunology
|November 7, 2006
PubMed

Insights

Inhaled beta-agonists are common for infant wheezing, but may harm lung health. This review examines their development, use, and potential negative effects in children.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacology

Background:

  • Inhaled beta-agonists are widely used for pediatric wheezing disorders.
  • Concerns exist regarding their potential adverse effects on lung health and symptoms.

Purpose of the Study:

  • To review beta-agonist receptor and smooth muscle development in children.
  • To evaluate the clinical utility of beta-agonists in pediatric wheezing and asthma.
  • To discuss the potential detrimental effects of beta-agonists in this population.

Main Methods:

  • Literature review of developmental biology.
  • Synthesis of evidence on clinical efficacy.
  • Discussion of safety data for beta-agonist medications.

Main Results:

  • Beta-agonist receptors and smooth muscle mature throughout fetal and childhood development.
  • Evidence for clinical utility in wheezing infants and asthmatic children is reviewed.
  • Potential detrimental effects of both short- and long-acting beta-agonists are considered.

Conclusions:

  • The use of inhaled beta-agonists in children requires careful consideration of developmental factors.
  • Further research is needed to fully understand the long-term safety and efficacy profiles.
  • Balancing benefits and risks is crucial for optimal management of pediatric respiratory conditions.

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...